Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-16

Clinical Trial Update: HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device [NA]

View source ↗

Summary

Clinical trial update on home vision monitoring (ForeseeHome) for progression to neovascular age-related macular degeneration in AREDS2 participants; results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ForeseeHome

Snippet

Sponsor: Notal Vision Ltd. | Conditions: Age Related Macular Degeneration | NA | Status: COMPLETED | Results posted: 2019-07-16